» Articles » PMID: 33161377

Prevention, Screening, Assessing and Managing of Non-adherent Behaviour in People with Rheumatic and Musculoskeletal Diseases: Systematic Reviews Informing the 2020 EULAR Points to Consider

Abstract

Objective: To analyse how non-adherence to prescribed treatments might be prevented, screened, assessed and managed in people with rheumatic and musculoskeletal diseases (RMDs).

Methods: An overview of systematic reviews (SR) was performed in four bibliographic databases. Research questions focused on: (1) effective interventions or strategies, (2) associated factors, (3) impact of shared decision making and effective communication, (4) practical things to prevent non-adherence, (5) effect of non-adherence on outcome, (6) screening and assessment tools and (7) responsible healthcare providers. The methodological quality of the reviews was assessed using AMSTAR-2. The qualitative synthesis focused on results and on the level of evidence attained from the studies included in the reviews.

Results: After reviewing 9908 titles, the overview included 38 SR on medication, 29 on non-pharmacological interventions and 28 on assessment. Content and quality of the included SR was very heterogeneous. The number of factors that may influence adherence exceed 700. Among 53 intervention studies, 54.7% showed a small statistically significant effect on adherence, and all three multicomponent interventions, including different modes of patient education and delivered by a variety of healthcare providers, showed a positive result in adherence to medication. No single assessment provided a comprehensive measure of adherence to either medication or exercise.

Conclusions: The results underscore the complexity of non-adherence, its changing pattern and dependence on multi-level factors, the need to involve all stakeholders in all steps, the absence of a gold standard for screening and the requirement of multi-component interventions to manage it.

Citing Articles

EducAR: implementing a multicomponent strategy to improve therapeutic adherence in rheumatoid arthritis.

Ahijon Lana M, Sivera Mascaro F, Fernandez-Nebro A, Muntadas Castello S, Perez M, Oton T RMD Open. 2025; 11(1).

PMID: 40021204 PMC: 11873333. DOI: 10.1136/rmdopen-2024-004989.


The overturn of Roe v. Wade beyond abortion: a snapshot of methotrexate accessibility for people with rheumatic and musculoskeletal diseases-a mixed methods study using Twitter data.

Negron J, Rodriguez-Malave M, Camacho C, Malave C, Rodriguez-Guzman V Rheumatol Int. 2023; 43(12):2293-2301.

PMID: 37572172 DOI: 10.1007/s00296-023-05407-1.


Associations Between Adherence to Self-Management Activities and Change in Function and Health Outcomes in the Rehabilitation of Patients with Rheumatic and Musculoskeletal Diseases.

Valaas H, Klokkerud M, Hildeskar J, Hagland A, Kjonli E, Mjosund K J Rehabil Med. 2023; 55:jrm00362.

PMID: 36633327 PMC: 9847370. DOI: 10.2340/jrm.v55.2214.


PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis.

Siebert S, Behrens F, Lubrano E, Martin N, Sharaf M, Contre C Rheumatol Ther. 2022; 10(2):489-505.

PMID: 36585602 PMC: 10011238. DOI: 10.1007/s40744-022-00518-w.


Association between VTE and antibiotic prophylaxis guideline compliance and patient-reported outcomes after total hip and knee arthroplasty: an observational study.

Badge H, Churches T, Naylor J, Xuan W, Armstrong E, Gray L J Patient Rep Outcomes. 2022; 6(1):110.

PMID: 36224453 PMC: 9556685. DOI: 10.1186/s41687-022-00502-6.


References
1.
Fautrel B, Balsa A, van Riel P, Casillas M, Capron J, Cueille C . Influence of route of administration/drug formulation and other factors on adherence to treatment in rheumatoid arthritis (pain related) and dyslipidemia (non-pain related). Curr Med Res Opin. 2017; 33(7):1231-1246. DOI: 10.1080/03007995.2017.1313209. View

2.
Ting T, Kudalkar D, Nelson S, Cortina S, Pendl J, Budhani S . Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus. J Rheumatol. 2011; 39(1):174-9. DOI: 10.3899/jrheum.110771. View

3.
Conn D, Pan Y, Easley K, Comeau D, Carlone J, Culler S . The effect of the Arthritis Self-Management Program on outcome in African Americans with rheumatoid arthritis served by a public hospital. Clin Rheumatol. 2012; 32(1):49-59. DOI: 10.1007/s10067-012-2090-5. View

4.
Bech B, Primdahl J, van Tubergen A, Voshaar M, Zangi H, Barbosa L . 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. Ann Rheum Dis. 2019; 79(1):61-68. DOI: 10.1136/annrheumdis-2019-215458. View

5.
Ravaud P, Flipo R, Boutron I, Roy C, Mahmoudi A, Giraudeau B . ARTIST (osteoarthritis intervention standardized) study of standardised consultation versus usual care for patients with osteoarthritis of the knee in primary care in France: pragmatic randomised controlled trial. BMJ. 2009; 338:b421. PMC: 2651104. DOI: 10.1136/bmj.b421. View